Erratum: A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence
暂无分享,去创建一个
Y. Okuno | S. Kojima | T. Fukao | N. Kondo | H. Ohnishi | H. Muramatsu | K. Matsumoto | T. Teramoto | Kimikazu Matsumoto | H. Ohnishi | Y. Takahashi | M. Ozeki | Takahide Teramoto | K. Kato | A. Shimada | S. Dovat | H. Sakaguchi | N. Yoshida | C. Song | H. Sakaguchi | C. Song | Yusuke Okuno | Akira Shimada | T. Fukao | Naomi Kondo | Yoshiyuki Takahashi | Koji Kato | Seiji Kojima
[1] S. South,et al. Loss of B Cells in Patients with Heterozygous Mutations in IKAROS. , 2016, The New England journal of medicine.
[2] Q. Li,et al. Epigenetic regulation of gene expression by Ikaros, HDAC1 and Casein Kinase II in leukemia , 2015, Leukemia.
[3] G. Smyth,et al. Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia , 2015, Leukemia.
[4] K. Horibe,et al. IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan , 2013, Cancer medicine.
[5] Chunhua Song,et al. Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the ikaros gene , 2012, Pediatric blood & cancer.
[6] K. Hung,et al. Ikaros Stability and Pericentromeric Localization Are Regulated by Protein Phosphatase 1* , 2009, Journal of Biological Chemistry.
[7] A. Ferrando,et al. Activating Notch1 mutations are an early event in T-cell malignancy of Ikaros point mutant Plastic/+ mice. , 2007, Leukemia research.
[8] P. Kastner,et al. Notch Activation Is an Early and Critical Event during T-Cell Leukemogenesis in Ikaros-Deficient Mice , 2006, Molecular and Cellular Biology.
[9] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[10] A. Perkins,et al. Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor. , 2003, Immunity.
[11] A. Fisher,et al. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. , 2000, Genes & development.
[12] A. Sharpe,et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. , 1996, Immunity.
[13] K. Georgopoulos,et al. Zinc finger‐mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. , 1996, The EMBO journal.
[14] K. Georgopoulos,et al. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma , 1995, Cell.
[15] A. Sharpe,et al. The ikaros gene is required for the development of all lymphoid lineages , 1994, Cell.